Benefits: Heals ulcers, IBS, and leaky gut Repairs tendons, ligaments & muscle tears Reduces joint inflammation Enhances angiogenesis (new blood vessel growth) Why Cellugenix: Tight batch control
B12 is vital for proper function and development of the brain, bone density, vision, and more
The available evidence consists primarily of animal studies and limited early-phase human trials, with no published phase III clinical trial data demonstrating efficacy in inflammatory bowel disease (IBD).[1][2] The literature describes BPC-157 as a stable gastric pentadecapeptide that was tested in phase II clinical trials for inflammatory bowel disease (referenced as PL 14736), with reports indicating it was "safe" and had "no side effects." However, a 2025 review emphasizes that BPC-157 "has not been approved for use in standard medicine by the FDA and other global regulatory authorities due to the absence of sufficient and comprehensive clinical studies confirming its health benefits in humans."[1][3][2] The preclinical evidence is extensive but limited to animal models
Jednak, jak przy kadej substancji, istnieje pewne ryzyko wystpienia skutkw ubocznych, szczeglnie przy dugotrwaym stosowaniu lub w wyszych dawkach
Related Blogs Disclaimer: Sermorelin is a prescription medication that must be obtained through a licensed medical provider following an appropriate clinical evaluation
